Log in to save to my catalogue
Log in to save to my catalogue

First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan...

| Ask | Become a Library member

First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8645705

First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset

About this item

Full title

First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset

Author / Creator

Satouchi, Miyako , Nosaki, Kaname , Takahashi, Toshiaki , Nakagawa, Kazuhiko , Aoe, Keisuke , Kurata, Takayasu , Sekine, Akimasa , Horiike, Atsushi , Fukuhara, Tatsuro , Sugawara, Shunichi , Umemura, Shigeki , Saka, Hideo , Okamoto, Isamu , Yamamoto, Nobuyuki , Sakai, Hiroshi , Kishi, Kazuma , Katakami, Nobuyuki , Horinouchi, Hidehito , Hida, Toyoaki , Okamoto, Hiroaki , Atagi, Shinji , Ohira, Tatsuo , Rong Han, Shi , Noguchi, Kazuo , Ebiana, Victoria and Hotta, Katsuyuki

Publisher

England: John Wiley & Sons, Inc

Journal title

Cancer science, 2021-12, Vol.112 (12), p.5000-5010

Language

English

Formats

Articles

Publication information

Publisher

England: John Wiley & Sons, Inc

Subjects

Subjects and topics

More information

Scope and Contents

Contents

This prespecified subanalysis of the global, randomized controlled phase III KEYNOTE‐024 study of pembrolizumab vs chemotherapy in previously untreated metastatic non‐small‐cell lung cancer without EGFR/ALK alterations and a programmed death‐ligand 1 (PD‐L1) tumor proportion score of 50% or greater evaluated clinical outcomes among patients enrolle...

Alternative Titles

Full title

First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8645705

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8645705

Other Identifiers

ISSN

1347-9032

E-ISSN

1349-7006

DOI

10.1111/cas.15144

How to access this item

Log in as a Library member

Full text available

About resource

View in old catalogue

Connecting people and collections